Shojaei AmirCHIEF SCIENTIFIC OFFICER
4
Filed Aug 17, 2026Period of report Aug 14, 20260001493152-26-038807
| Transaction | Security | Shares | Price | ValueValue (shares × price) | Held after | Ownership |
|---|---|---|---|---|---|---|
SaleAug 14, 2026 | Common StockF1 | 11,250 | $40.00 | $450.00K | 0 | Direct |
Filing footnotes · 2
- F1The sale reported in this Form 4 was effected as part of a broker-assisted same-day sale transaction in connection with the option exercise reported herein to fund the aggregate exercise price and related transaction costs. The Reporting Person did not retain any shares acquired upon exercise.
- F2The option was granted on January 6, 2025. The shares subject to the option vest according to the following schedule: 25% of the shares vested at the one-year anniversary of the date of grant, and the remaining shares vest over the next three years in 12 equal quarterly installments until fully vested and exercisable on January 6, 2029.